Modulation of TRAIL resistance in colon carcinoma cells: Different contributions of DR4 and DR5
2011

Understanding TRAIL Resistance in Colon Cancer Cells

publication Evidence: moderate

Author Information

Author(s): Caroline MM van Geelen, Bodvael Pennarun, Le Phuong TK Le, Elisabeth GE de Vries, Steven de Jong

Primary Institution: University Medical Center Groningen, University of Groningen

Hypothesis

The study investigates the contributions of death receptors DR4 and DR5 to rhTRAIL sensitivity and resistance in colon carcinoma cells.

Conclusion

The study highlights a critical difference between DR4- and DR5-mediated apoptotic signaling modulation, which may influence future treatment strategies.

Supporting Evidence

  • SW948 cells were sensitive to all three DR-targeting agents tested.
  • Agonistic DR4 and DR5 antibodies induced equivalent DISC formation.
  • SW948-TR cells were cross-resistant to all DR-targeting agents due to decreased caspase 8 expression levels.
  • MG-132 and IFN-gamma pretreatment restored caspase 8 protein expression in SW948-TR cells.

Takeaway

This research shows that one part of the cell's death signaling system is more important than another for killing cancer cells, which could help doctors choose better treatments.

Methodology

The study used human colon carcinoma cell lines to assess the effects of rhTRAIL and agonistic DR4/DR5 antibodies on cell viability and apoptosis.

Digital Object Identifier (DOI)

10.1186/1471-2407-11-39

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication